Therapy News and Research

RSS

NeoTract treats first patient in US with UroLift System

NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.

24 Sep 2013

Sulfasalazine drug does not reduce diarrhea for patients receiving pelvic radiation therapy: Study

Sulfasalazine, a drug commonly prescribed to reduce diarrhea in patients with inflammatory bowel disease, does not reduce diarrhea in patients receiving radiation therapy for cancers in the pelvic area a Mayo Clinic-led study has found.

24 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013

Stereotactic radiosurgery improves survival in adult brain cancer patients under 50

When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

The American Society for Radiation Oncology will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO's 55th Annual Meeting, September 22-25, 2013, in Atlanta.

24 Sep 2013

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

A secondary analysis of the historic RTOG 9202 prostate cancer trial examined results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy, and concluded that there were no additional benefits when compared to short-term hormonal therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Woman suffering from chronic pelvic pain for nearly two decades now pain free

Anne Mosley developed intense pelvic pain while she was pregnant with her youngest child 17 years ago. The pain was caused by a grape-sized pocket of fluid on her urethra, which became infected.

24 Sep 2013

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.

24 Sep 2013

Depression in cancer patients who receive RT can be identified by 2-item questionnaire

Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Lung cancer patients who received IMRT report less decline in their QOL

An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

FDA approves revised labeling for Sapien Transcatheter Heart Valve

The U.S. Food and Drug Administration today approved revised labeling for the Sapien Transcatheter Heart Valve, making the device available to an expanded group of patients who have inoperable aortic valve stenosis, a disease of the heart valves that causes narrowing of the aortic valve, restricting blood flow from the heart.

24 Sep 2013

Proton radiotherapy proves to be cost-effective in treating pediatric brain tumors

Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Marriage improves outcomes among patients with cancer, says oncologist

New results from a large retrospective study of the National Cancer Institute's SEER database show that patients with cancer who were married at the time of diagnosis live markedly longer compared to unmarried patients.

24 Sep 2013

Researchers develop first imaging tool to examine myelin damage in MS

Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.

24 Sep 2013

UT Arlington team to lead $1M NSF grant project to develop smart rehabilitation system

A UT Arlington multidisciplinary team will lead a three-year, $1 million National Science Foundation grant project to develop iRehab, a smart rehabilitation system that can adapt and personalize therapy programs based on a patient's needs and constraints.

24 Sep 2013

Protecting stem cells around hippocampus in brain reduces rate of memory loss in cancer patients

Protecting the stem cells that reside in and around the hippocampus - a C-shaped area in the temporal lobe on both sides of the brain associated with the ability to form and store memories - substantially reduces the rate of cancer patients' memory loss during whole-brain radiotherapy without a significant risk of recurrence in that area of the brain, a new study shows.

24 Sep 2013

TAS therapy prior to radiation therapy yields favorable outcomes in PCa patients

A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO) 55th Annual Meeting.

24 Sep 2013

Two-question screening test may reveal depression in cancer patients

Cancer patients can be accurately screened for major depression with a simple two-question survey, according to a study presented Sept. 23 at the American Society for Radiation Oncology's 55th Annual Meeting.

24 Sep 2013

Respicardia reports results from remede System Pilot Study for central sleep apnea treatment

Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.

24 Sep 2013

Therapy News and Research

NeoTract treats first patient in US with UroLift System

Sulfasalazine drug does not reduce diarrhea for patients receiving pelvic radiation therapy: Study

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Stereotactic radiosurgery improves survival in adult brain cancer patients under 50

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

Woman suffering from chronic pelvic pain for nearly two decades now pain free

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

Depression in cancer patients who receive RT can be identified by 2-item questionnaire

Lung cancer patients who received IMRT report less decline in their QOL

FDA approves revised labeling for Sapien Transcatheter Heart Valve

Proton radiotherapy proves to be cost-effective in treating pediatric brain tumors

Marriage improves outcomes among patients with cancer, says oncologist

Researchers develop first imaging tool to examine myelin damage in MS

UT Arlington team to lead $1M NSF grant project to develop smart rehabilitation system

Protecting stem cells around hippocampus in brain reduces rate of memory loss in cancer patients

TAS therapy prior to radiation therapy yields favorable outcomes in PCa patients

Two-question screening test may reveal depression in cancer patients

Respicardia reports results from remede System Pilot Study for central sleep apnea treatment

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News